iSpecimen Statistics
Total Valuation
iSpecimen has a market cap or net worth of $3.45 million. The enterprise value is $981,883.
Important Dates
The next estimated earnings date is Monday, November 4, 2024, before market open.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
iSpecimen has 654,851 shares outstanding. The number of shares has increased by 7.82% in one year.
Shares Outstanding | 654,851 |
Shares Change (YoY) | +7.82% |
Shares Change (QoQ) | +24.18% |
Owned by Insiders (%) | 17.05% |
Owned by Institutions (%) | 10.37% |
Float | 543,208 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.22 |
Forward PS | 0.52 |
PB Ratio | 0.51 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.00.
Current Ratio | 0.90 |
Quick Ratio | 0.86 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -44.05 |
Financial Efficiency
Return on equity (ROE) is -98.03% and return on invested capital (ROIC) is -61.18%.
Return on Equity (ROE) | -98.03% |
Return on Assets (ROA) | -43.46% |
Return on Capital (ROIC) | -61.18% |
Revenue Per Employee | $198,236 |
Profits Per Employee | -$192,362 |
Employee Count | 53 |
Asset Turnover | 0.71 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.09% in the last 52 weeks. The beta is 1.59, so iSpecimen's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | -45.09% |
50-Day Moving Average | 5.08 |
200-Day Moving Average | 6.41 |
Relative Strength Index (RSI) | 54.09 |
Average Volume (20 Days) | 600,981 |
Short Selling Information
The latest short interest is 64,238, so 9.81% of the outstanding shares have been sold short.
Short Interest | 64,238 |
Short Previous Month | 554,386 |
Short % of Shares Out | 9.81% |
Short % of Float | 11.83% |
Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, iSpecimen had revenue of $10.51 million and -$10.20 million in losses. Loss per share was -$21.17.
Revenue | 10.51M |
Gross Profit | 5.26M |
Operating Income | -10.25M |
Pretax Income | -10.20M |
Net Income | -10.20M |
EBITDA | -10.03M |
EBIT | -10.25M |
Loss Per Share | -$21.17 |
Full Income Statement Balance Sheet
The company has $2.15 million in cash and $29,130 in debt, giving a net cash position of $2.12 million or $3.24 per share.
Cash & Cash Equivalents | 2.15M |
Total Debt | 29,130 |
Net Cash | 2.12M |
Net Cash Per Share | $3.24 |
Equity (Book Value) | 6.09M |
Book Value Per Share | 9.30 |
Working Capital | -577,321 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$4.90 million and capital expenditures -$14,869, giving a free cash flow of -$4.92 million.
Operating Cash Flow | -4.90M |
Capital Expenditures | -14,869 |
Free Cash Flow | -4.92M |
FCF Per Share | -$7.51 |
Full Cash Flow Statement Margins
Gross margin is 50.09%, with operating and profit margins of -97.53% and -97.04%.
Gross Margin | 50.09% |
Operating Margin | -97.53% |
Pretax Margin | -97.04% |
Profit Margin | -97.04% |
EBITDA Margin | -95.45% |
EBIT Margin | -97.53% |
FCF Margin | -70.02% |